Author: Ashleigh Tuite; David N Fisman; Amy L Greer
Title: Mathematical modeling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada Document date: 2020_3_26
ID: e4pr78n0_2
Snippet: This pathogen represents a significant challenge for public health, pandemic planning, and healthcare systems. The SARS-CoV-2 virus is highly transmissible (4) (5) (6) (7) . It causes moderate to severe clinical outcomes in approximately 20% of all recognized infected individuals (5, 8, 9) . In the absence of a vaccine, public health responses have focused on the use of non-pharmaceutical interventions (NPIs) (10) . These NPIs include: (1) "case-.....
Document: This pathogen represents a significant challenge for public health, pandemic planning, and healthcare systems. The SARS-CoV-2 virus is highly transmissible (4) (5) (6) (7) . It causes moderate to severe clinical outcomes in approximately 20% of all recognized infected individuals (5, 8, 9) . In the absence of a vaccine, public health responses have focused on the use of non-pharmaceutical interventions (NPIs) (10) . These NPIs include: (1) "case-based" measures such as testing, contact tracing, isolation, and quarantine, and (2) "non-case-based" measures such as reducing the probability of transmission given an effective contact (e.g. hand hygiene, and cough etiquette), and social distancing measures to reduce the contact rate in the population. Social distancing minimizes opportunities for person-to-person transmission of the virus to occur. These social distancing measures include some combination of school closure, teleworking, cancellation of group activities and events, and a general overall reduction in community contacts. While they are expected to be effective in reducing transmission of SARS-CoV-2, they are also associated with substantial economic costs and social disruption.
Search related documents:
Co phrase search for related documents- clinical outcome and economic cost: 1, 2
- clinical outcome and effective contact: 1
- clinical outcome and group activity: 1
- clinical outcome and healthcare system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- clinical outcome and infected individual: 1
- clinical outcome and overall reduction: 1, 2, 3, 4, 5
- clinical outcome and pandemic planning: 1, 2, 3
- clinical outcome and person person: 1, 2, 3, 4
- clinical outcome and person person transmission: 1
- clinical outcome and public health: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- clinical outcome and public health response: 1, 2
- clinical outcome and SARS transmission: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- clinical outcome and SARS virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61
- clinical outcome and significant challenge: 1, 2, 3
- clinical outcome and vaccine absence: 1, 2, 3, 4, 5
- community contact and contact rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- community contact and contact tracing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- community contact and distancing measure: 1, 2
- community contact and effective contact: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
Co phrase search for related documents, hyperlinks ordered by date